Funding from the Anthem-backed series E round will support the commercialisation of Sera's biomarker tests, which predict the chances of preterm births.

The cancer therapy developer has now collected more than $240m altogether, having completed a series C round that included Roche Venture Fund.

Stripe has reinvested in the teenager-focused digital banking services provider, which also counts Sesame Workshop and WndrCo as existing backers.

Alexandria Venture Investments returned for a series B round that increased the precision oncology drug developer's overall funding to over $150m.

Insurance provider Assurant's corporate venturing unit has had three portfolio companies enter reverse merger deals since the start of March.

Coinbase and Genies both participated in a series B round that pushed the blockchain infrasructure provider's valuation past $500m.

Fungal infection treatment developer Amplyx Pharmaceuticals had disclosed $142m in funding from investors including Pfizer and Lundbeckfonden Ventures.

Applied Ventures helped assay provider Ultivue close a $50m round while clean energy producer Sunseap has followed a $72m series D4 round with more corporate funding.

Wells Fargo Strategic Capital was among the investors in a series D round valuing the child-focused banking platform developer at $2.3bn.

The CMFG Ventures-backed challenger bank’s latest round valued it at $2.2bn and pushed its total funding past $400m.